Skip to main content
. 2021 Dec 17;8:799934. doi: 10.3389/fmolb.2021.799934

TABLE 1.

Characteristics of the eligible studies.

Author, year Country Population Participant s age (years) Sample size: tibolone/placebo Duration Baseline BMI(kg/m2) Outcome Vitamin D dose (IU/day)
Kerksick.et al. (2020) (a) (CTL = no diet + exercise control) USA Healthy postmenopausal women 56.1 11/9 14 weeks 31.8 LDL-C, TC, HDL-C, TG 400 (calcium with Vitamin D)
Kerksick.et al. (2020) (b) (LCHC = low calorie high carbohydrate diet) USA Healthy postmenopausal women 54.4 15/20 14 weeks 32.6 LDL-C, TC, HDL-C, TG 400 (calcium with Vitamin D)
Kerksick.et al. (2020) (c) (LCHP = low calorie high protein diet) USA Healthy postmenopausal women 52.4 16/18 14 weeks 36.4 LDL-C, TC, HDL-C, TG 400 (calcium with Vitamin D)
Ferreira et al. (2020) Brazil Healthy postmenopausal women 58.8 80/69 9 months 29.4 LDL-C, TC, HDL-C, TG 1000
Bislev et al. (2018) Denmark Healthy postmenopausal 65 40/41 12 weeks 27 LDL-C, HDL-C, TG 2800
Munoz-Aguirre et al. (2015) Mexico Healthy postmenopausal women 43.55 52/52 6 months 30.8 LDL-C, TC, HDL-C, TG 4000
Moghassemi and Marjani. (2014) Iran Healthy postmenopausal women 52.73 38/36 12 weeks 29.98 LDL-C, TC, HDL-C, TG 2000
Wood et al. (2012) (a) United Kingdom Healthy postmenopausal women 63.5 97/50 1 year 26.6 LDL-C, TC, HDL-C, TG 400
Wood et al. (2012) (b) United Kingdom Healthy postmenopausal women 64.1 95/50 1 year 26.8 LDL-C, TC, HDL-C, TG 1000
Heikkinen et al. (1997) (a) Finland Healthy postmenopausal women 52.8 83/95 3 years 26.8 LDL-C, TC, HDL-C, TG 300
Heikkinen et al. (1997) (b) Finland Healthy postmenopausal women during postmenopausal hormone replacement therapy 52.4 77/65 3 years 26.4 LDL-C, TC, HDL-C, TG 300

Note: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, serum triglycerides; mg/d, milligrams per day; USA, United States of America.